Abstract 4997: PLK1 promotes the metastasis and drug resistance in melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4997
Abstract: Melanoma is one of the most frequently diagnosed cancers in the caucasian population of both genders. The survival rate of advanced melanoma patients will be exceedingly poor, as low as 27.3%. BRAF-V600E is the most… read more here.
Keywords: metastasis drug; plk1; melanoma; plk1 promotes ... See more keywords
The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2021.784983
Abstract: Metastasis and relapse are major causes of cancer-related fatalities. The elucidation of relevant pathomechanisms and adoption of appropriate countermeasures are thus crucial for the development of clinical strategies that inhibit malignancy progression as well as… read more here.
Keywords: cancer; drug resistance; metastasis; cancer metastasis ... See more keywords
Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance
Sign Up to like & getrecommendations! Published in 2023 at "Non-Coding RNA"
DOI: 10.3390/ncrna9010012
Abstract: Cancer is responsible for more than 10 million deaths every year. Metastasis and drug resistance lead to a poor survival rate and are a major therapeutic challenge. Substantial evidence demonstrates that an increasing number of… read more here.
Keywords: metastasis drug; linc ror; non coding; cancer ... See more keywords